CCND3 and cancer: Cyclin D3 is overexpressed in specific human cancers and is subject to point mutations specifically in Burkitt’s lymphoma [6]; the specific residue targeted, Thr-283 has been implicated in regulating cyclin D3 protein destruction [26].